Keystone Nano, Inc.

KN is developing products to treat cancer with unique, effective, targeted nano therapies and is starting clinical testing in 2016.

Operating in biotechnology, health care, therapeutics based in Great Lakes, Northeastern US, Keystone Nano, Inc. was founded in 2005.

Within the biotechnology, health care, therapeutics space, the company focuses on its core offering rather than a broad product line.

The company is recorded as being based in Great Lakes, Northeastern US.

It is recorded at the SBIR/STTR stage.

Its team size is recorded as c_00001_00010 employees.

Total disclosed funding stands at about $4K.

Website: www.pendreabio.com